report
lactoferrin
lf
particip
host
immun
respons
sever
acut
respiratori
syndrom
coronaviru
sarscov
invas
enhanc
nk
cell
activ
stimul
neutrophil
aggreg
adhes
investig
role
lf
entri
sar
pseudoviru
cell
result
reveal
lf
inhibit
sar
pseudoviru
infect
dosedepend
manner
analysi
suggest
lf
abl
block
bind
spike
protein
host
cell
indic
lf
exert
inhibitori
function
viral
attach
stage
howev
lf
disrupt
interact
spike
protein
angiotensinconvert
enzym
function
receptor
sarscov
previou
studi
shown
lf
coloc
wide
distribut
cellsurfac
heparan
sulfat
proteoglycan
hspg
experi
also
confirm
conclus
treatment
cell
heparinas
exogen
heparin
prevent
bind
spike
protein
host
cell
inhibit
sar
pseudoviru
infect
demonstr
hspg
provid
bind
site
sarscov
invas
earli
attach
phase
taken
togeth
result
suggest
addit
hspg
essenti
cellsurfac
molecul
involv
sarscov
cell
entri
lf
may
play
protect
role
host
defens
sarscov
infect
bind
hspg
block
preliminari
interact
sarscov
host
cell
find
may
provid
understand
sarscov
pathogenesi
aid
treatment
deadli
diseas
sever
acut
respiratori
syndrom
sar
infecti
diseas
emerg
guangdong
provinc
china
novemb
deadli
diseas
rapidli
spread
mani
countri
around
world
mortal
rate
approxim
sar
present
atyp
pneumonia
often
lead
acut
respiratori
distress
syndrom
respiratori
failur
main
caus
death
unusu
infecti
diseas
becom
major
threat
public
health
social
stabil
sinc
outbreak
date
effect
therapeut
strategi
prevent
vaccin
avail
treatment
sar
april
novel
coronaviru
sar
coronaviru
sarscov
identifi
etiolog
agent
sar
sarscov
envelop
positivestrand
rna
viru
larg
rna
genom
approxim
nucleotid
length
encod
nonstructur
replicas
complex
structur
protein
includ
spike
envelop
e
membran
nucleocapsid
n
protein
spike
protein
envelop
protein
respons
invas
host
cell
threedimension
structur
analys
suggest
spike
protein
compos
two
subunit
mediat
sarscov
bind
receptor
host
cell
trigger
viru
host
cell
membran
fusion
angiotensinconvert
enzym
metallopeptidas
identifi
one
function
receptor
sarscov
respons
bind
spike
protein
mediat
sarscov
entri
host
cell
crystallograph
studi
shown
segment
contain
amino
acid
critic
receptorbind
domain
receptor
highli
express
human
lung
alveolar
epitheli
cell
enterocyt
small
intestin
brush
border
proxim
tubular
cell
kidney
locat
express
consist
tissu
tropism
pathogenesi
sarscov
infect
coreceptor
cellular
molecul
may
requir
facilit
sarscov
invas
sarscov
infect
host
immun
respons
viru
trigger
innat
immun
respons
play
essenti
role
inhibit
viral
infect
report
mani
gene
involv
innat
immun
respons
encod
lactoferrin
lf
lipocalin
particip
sarscov
clearanc
among
upregul
gene
lf
express
elev
approxim
fold
sar
patient
compar
healthi
control
studi
demonstr
lf
exert
function
process
sarscov
infect
enhanc
nk
cell
activ
stimul
neutrophil
aggreg
adhes
howev
bioactiv
lactoferrin
complet
understood
lf
multifunct
protein
present
extern
secret
includ
saliva
tear
milk
nasal
bronchial
secret
gastrointestin
fluid
urin
mucos
secret
import
constitu
neutrophil
granul
leukocyt
lf
possess
strong
antivir
activ
broad
spectrum
rna
dna
virus
sindbi
viru
cytomegaloviru
herp
simplex
viru
semliki
forest
viru
human
polyomaviru
human
papillomaviru
echoviru
human
immunodefici
viru
rotaviru
virus
typic
util
common
molecul
cell
membran
facilit
invas
cell
molecul
includ
heparan
sulfat
proteoglycan
hspg
provid
first
anchor
site
cell
surfac
help
viru
make
primari
contact
host
cell
shown
lf
abl
prevent
intern
virus
bind
hspg
present
cell
properti
lf
confer
protect
host
viral
infect
base
find
hypothes
anoth
underli
mechan
antisarscov
effect
lf
involv
capabl
bind
extens
distribut
hspg
molecul
host
cell
result
indic
hspg
provid
preliminari
dock
site
cell
surfac
play
import
role
process
sar
pseudoviru
cell
entri
lf
block
infect
sar
pseudoviru
bind
hspg
suggest
may
exert
protect
role
host
immun
defens
sarscov
invas
plasmid
pqcxix
sarscov
spike
proteinencod
vector
gagpol
express
plasmid
kindli
provid
dr
wenhui
li
vsvg
plasmid
encod
vesicular
stomat
viru
vsv
g
glycoprotein
kindli
provid
dr
xiaozhong
peng
peke
union
medic
colleg
fc
cell
line
stabli
express
human
igg
fc
fragment
respect
gener
laboratori
describ
previous
human
colon
carcinomaderiv
cell
african
green
monkey
kidneyderiv
vero
cell
provid
american
type
cultur
collect
atcc
cell
grown
highglucos
dulbecco
modifi
eagl
medium
dmem
hyclon
supplement
fetal
bovin
serum
fb
humidifi
incub
co
sar
pseudotyp
virus
produc
report
previous
briefli
cell
confluenc
dish
cotransfect
mg
pqcxix
mg
mg
gagpol
express
plasmid
use
lipofectamin
invitrogen
transfect
viral
supernat
harvest
filter
screen
pore
size
viral
particl
without
glycoprotein
neg
control
prepar
pqcxix
gagpol
plasmid
method
pqcxix
gagpol
vsvg
plasmid
use
vsvg
pseudotyp
viru
packag
wayvir
stock
aliquot
frozen
longterm
storag
shortterm
storag
dramat
affect
viral
titer
viral
titer
determin
previous
describ
total
cell
seed
plate
hour
cell
wash
phosphatebuff
salin
pb
two
time
cultur
replac
fresh
dmem
without
fb
bovin
lf
wako
heparin
sigmaaldrich
indic
concentr
ad
cell
h
min
respect
subsequ
transduc
unit
tu
sar
pseudovirus
ad
cell
incub
h
concentr
lf
heparin
maintain
throughout
process
viral
infect
simultan
mm
bovin
serum
albumin
bsa
sigmaaldrich
pb
use
control
method
describ
respect
unbound
pseudovirion
remov
three
wash
pb
cell
cultur
fresh
dmem
fb
h
sar
pseudovirusinfect
gfpexpress
cell
observ
fluoresc
microscopi
nikon
eclips
te
count
flow
cytometri
beckman
coulter
epic
elit
est
test
sar
pseudoviru
vero
cell
perform
method
describ
infect
cell
vsvg
pseudotyp
viru
presenc
lf
heparin
carri
way
viral
particl
without
glycoprotein
incub
cell
test
whether
capabl
infect
cell
seed
plate
next
day
incub
h
lf
concentr
mm
mm
mm
mm
cell
treat
sar
pseudoviru
particl
h
mm
bsa
use
control
pseudoviruscontain
supernat
remov
cell
wash
three
time
pb
growth
fresh
dmem
fb
h
cell
harvest
analyz
gfp
express
level
western
blot
band
densiti
calcul
western
blot
use
quantiti
one
softwar
bind
assay
human
igg
fc
prepar
describ
hongliang
wang
et
al
laboratori
briefli
fc
express
fc
cell
respect
recombin
protein
compos
solubl
extracellular
region
amino
acid
sar
spike
protein
human
igg
fc
fuse
c
terminu
protein
purifi
use
protein
column
ge
healthcar
protein
concentr
measur
bca
assay
kit
biorad
cell
confluenc
harvest
dish
cell
expos
nm
h
incub
lf
heparin
h
min
respect
concentr
lf
heparin
maintain
throughout
process
incub
fc
protein
use
control
unbound
remov
three
wash
pb
cell
surfac
bound
detect
fitclabel
mous
antihuman
igg
fc
secondari
antibodi
santa
cruz
three
wash
pb
mean
fluoresc
intens
mfi
group
measur
flow
cytometri
result
analyz
flowjo
softwar
elisa
immunosorb
plate
coat
ml
mgml
fc
sodium
carbon
buffer
nahco
ph
overnight
follow
block
h
ml
bovin
serum
albumin
bsa
pb
well
coat
fc
pb
use
neg
control
blank
control
respect
cell
lyse
harvest
contain
supernat
determin
whether
lf
interfer
interact
treat
lf
mm
lf
ad
coat
well
contain
supernat
respect
time
incub
h
lf
untreat
use
control
lf
pretreat
untreat
ad
coat
well
without
lf
h
allow
interact
well
wash
six
time
pbst
phosphatebuff
salin
tween
incub
ml
mous
antimyc
antibodi
santa
cruz
dilut
pb
h
plate
wash
horseradish
peroxidaseconjug
goat
antimous
antibodi
santa
cruz
ad
well
incub
h
wash
six
time
pbst
plate
develop
ml
tetramethylbenzidin
substrat
reaction
termin
ml
h
absorb
read
nm
oregon
green
lf
prepar
accord
manual
provid
invitrogen
use
concentr
mm
pb
ph
cell
grown
coverslip
plate
incub
oregon
greenlabel
lf
h
unbound
lf
cultur
supernat
remov
three
wash
step
cell
fix
paraformaldehyd
min
subsequ
cell
membran
nuclei
stain
perchlor
dii
sigmaaldrich
sigmaaldrich
respect
subcellular
local
lf
observ
use
confoc
laserscan
microscopi
leica
tc
imag
analyz
use
leica
confoc
softwar
heparan
sulfat
remov
cell
surfac
cell
treatment
heparinas
sigmaaldrich
cell
grown
confluenc
plate
wash
three
time
dmem
without
fb
incub
unit
heparinas
per
ml
h
heparinas
buffer
mm
trishcl
mm
nacl
mm
cacl
bsa
ph
three
wash
pb
cell
resuspend
fresh
dmem
without
fb
subject
subsequ
sar
pseudoviru
vsvg
pseudoviru
treatment
describ
method
also
appli
treatment
vero
cell
chondroitin
sulfat
cell
surfac
digest
chondroitinas
abc
sigmaaldrich
way
data
present
least
three
independ
experi
statist
analys
perform
use
student
ttest
differ
consid
signific
addit
replicationcompet
virus
pseudovirus
becom
ideal
tool
investig
cell
entri
sarscov
without
safeti
concern
sar
pseudoviru
possess
morpholog
characterist
replicationcompet
sarscov
sarscov
spike
protein
envelop
membran
mimic
sarscov
process
cell
entri
use
three
plasmid
produc
sar
pseudoviru
particl
gag
pol
pqcxix
gagpol
plasmid
carri
lentivir
gene
gagpol
express
capsid
protein
enzym
replic
pqcxix
encod
lentivir
packag
signal
gene
gfp
respons
sar
spike
protein
express
coexpress
three
plasmid
cell
result
incorpor
sarscov
spike
protein
bud
lentivir
particl
envelop
along
report
gfp
enabl
analysi
spikemedi
entri
host
cell
report
lf
abl
inhibit
broad
rang
virus
earli
attach
stage
establish
antivir
effect
lf
sarscov
util
sar
pseudoviru
cell
perform
seri
transduct
assay
presenc
absenc
bovin
lf
facilit
detect
sar
pseudoviru
intern
laboratori
gener
cell
line
stabli
express
surfaceloc
myc
tag
fuse
c
terminu
demonstr
previou
studi
cell
line
perfect
tool
studi
interact
sarscov
host
cell
particularli
stage
sarscov
cell
entri
incub
cell
differ
concentr
lf
h
sar
pseudovirus
ad
lftreat
cell
test
effect
lf
sar
pseudoviru
infect
shown
figur
number
gfp
express
cell
decreas
sharpli
increas
concentr
lf
cell
entri
sar
pseudovirus
lead
gfp
express
result
suggest
infect
cell
sar
pseudoviru
dramat
inhibit
presenc
lf
util
western
blot
examin
gfp
express
lftreat
cell
incub
sar
pseudoviru
found
amount
gfp
protein
reduc
presenc
lf
fig
degre
inhibit
correl
concentr
lf
time
gfp
express
cell
test
flow
cytometri
incub
lf
sar
pseudoviru
figur
demonstr
lf
inhibit
sar
pseudoviru
infect
dosedepend
manner
inhibitori
concentr
approxim
mm
howev
gfp
express
cell
incub
viral
particl
without
spike
protein
indic
sar
pseudoviru
cell
entri
mediat
spike
protein
data
describ
suggest
lf
prevent
sar
pseudoviru
infect
host
cell
inhibitori
effect
dose
depend
previou
studi
reveal
infect
host
cell
sarscov
driven
spike
protein
envelop
protein
respons
attach
fusion
viral
cellular
membran
thu
prevent
effect
lf
sar
pseudoviru
infect
may
occur
target
attach
fusion
step
determin
whether
inhibitori
effect
due
lf
block
interact
spike
protein
host
cell
incub
lf
pretreat
cell
h
solubl
truncat
form
sar
cov
spike
protein
retain
extracellular
region
amino
acid
human
igg
fc
fuse
c
terminu
treatment
describ
mfi
group
analyz
flow
cytometri
shown
figur
lf
effect
block
bind
cell
suggest
lf
exert
inhibitori
effect
sar
pseudoviru
intern
initi
attach
stage
cell
entri
sar
cov
rather
complex
process
trigger
interact
spike
protein
receptor
andor
cofactor
cell
surfac
establish
serv
function
receptor
sarscov
infect
lectin
dcsign
dendrit
cellspecif
icamgrab
nonintegrin
relat
molecul
may
also
play
import
role
sarscov
invas
date
underli
mechan
viral
entri
fulli
understood
investig
need
elucid
subtl
process
test
whether
lf
prevent
spike
protein
bind
main
receptor
ad
lf
contain
supernat
incub
h
mix
solut
togeth
immunosorb
plate
examin
interact
elisa
result
suggest
lf
disrupt
bind
fig
thu
lf
may
employ
mechan
inhibit
attach
sar
pseudoviru
host
cell
spike
protein
protein
sarscov
envelop
respons
entri
host
cell
bind
spike
protein
receptor
initi
fusion
viral
cellular
membran
base
fact
deduc
lf
block
bind
spike
protein
could
interact
anoth
molecul
cell
surfac
therebi
play
inhibitori
role
sar
pseudoviru
cell
entri
determin
subcellular
local
lf
label
lf
oregon
green
fluoresc
dye
incub
label
lf
cell
time
cell
membran
stain
red
membran
dye
dii
accord
confoc
microscopi
result
lf
present
cell
membran
fig
previou
studi
establish
lf
mediat
inhibit
viral
infect
interf
viruscel
interact
bind
widespread
famili
cellsurfac
molecul
hspg
hspg
complex
macromolecul
consist
unbranch
heparan
sulfat
hs
polysaccharid
chain
compos
repeat
disaccharid
subunit
hexuron
acid
hexosamin
coval
link
core
protein
oglycosid
linkag
bind
lf
hspg
prevent
first
contact
viru
host
cell
thu
prevent
subsequ
infect
ascertain
whether
lf
interact
cellsurfac
hspg
molecul
use
heparin
interfer
bind
lf
target
cell
due
similar
structur
composit
exogen
heparin
wide
util
solubl
hs
analog
competit
inhibit
interact
hspg
ligand
prior
incub
oregon
greenlabel
lf
cell
treat
heparin
differ
concentr
mfi
analyz
detect
amount
lf
bind
group
shown
figur
exogen
heparin
effici
prevent
lf
bind
cell
indic
lf
local
cell
surfac
mainli
interact
hspg
investig
whether
lf
inhibit
bind
cell
due
bind
cellsurfac
hspg
ad
incub
heparin
pretreat
cell
lf
figur
show
heparin
neutral
inhibitori
effect
lf
bind
host
cell
dosedepend
manner
suggest
anchor
site
lf
cell
surfac
provid
hs
moieti
hspg
hs
analog
heparin
compet
lf
bind
hspg
prevent
cell
bind
next
experi
examin
whether
heparin
could
neutral
lfmediat
inhibit
sar
pseudoviru
infect
cell
manner
prior
sar
pseudoviru
infect
ad
heparin
cell
incub
heparintr
cell
lf
h
shown
figur
ad
heparin
increas
infect
sar
pseudoviru
presenc
lf
compar
control
evid
support
conclus
lf
block
adsorpt
intern
sar
pseudoviru
bind
hspg
cell
surfac
interestingli
anoth
phenomenon
also
captur
attent
ad
heparin
alon
also
prevent
cell
entri
sar
pseudoviru
host
cell
fig
result
consist
previou
find
heparin
reduc
infect
vero
cell
replicationcompet
sarscov
evid
impli
hspg
play
import
role
sarscov
cell
entri
furthermor
found
instead
increas
cell
entri
incub
cell
mm
heparin
mm
lf
curtail
infect
sar
pseudoviru
compar
cell
treat
mm
heparin
mm
lf
one
reason
explan
result
excess
heparin
compet
hs
chain
cell
surfac
prevent
adsorpt
sar
pseudoviru
host
cell
data
indic
hspg
import
molecul
involv
sar
pseudoviru
cell
entri
prove
involv
hspg
sarscov
entri
process
first
util
test
whether
hspg
particip
viral
adsorpt
step
prior
incub
h
cell
treat
heparin
min
mean
fluoresc
intens
analysi
demonstr
bind
cell
effici
block
addit
heparin
fig
use
heparinas
degrad
hs
chain
cell
surfac
found
enzymat
remov
hs
polysaccharid
result
reduc
abil
bind
host
cell
fig
suggest
addit
hspg
act
anoth
dock
site
sarscov
cell
surfac
presenc
heparinaseresist
oligosaccharid
may
give
rise
incomplet
inhibit
provid
support
evid
requir
cellsurfac
hspg
sarscov
infect
ad
heparin
cell
incub
cell
sar
pseudoviru
treatment
host
cell
cellular
hs
analog
dramat
decreas
infect
sar
pseudoviru
fig
indic
sar
pseudoviru
cell
entri
block
competit
inhibit
part
heparin
bind
site
provid
hspg
import
effect
infect
enzymat
degrad
hs
chain
cell
surfac
also
led
resist
hsdefici
cell
sar
pseudoviru
infect
fig
demonstr
hs
chain
hspg
involv
sar
pseudoviru
cell
entri
hspg
wide
distribut
cell
membran
like
serv
initi
anchor
site
facilit
preliminari
contact
viru
host
cell
subsequ
concentr
virus
cell
surfac
accord
previou
studi
viral
particl
transfer
low
affin
hspg
specif
high
affin
entri
receptor
result
intern
host
cell
hspg
suffici
sarscov
entri
hspg
wide
express
mammalian
cell
howev
sarscov
found
limit
host
cell
lung
alveolar
epitheli
cell
enterocyt
small
intestin
brush
border
proxim
tubular
cell
kidney
therefor
hspg
may
play
import
role
promot
sarscov
infect
facilit
access
specif
entri
receptor
howev
chondroitin
sulfat
remov
cell
surfac
enzymat
digest
sar
pseudoviru
could
still
effect
infect
host
cell
suggest
compar
hspg
chondroitin
sulfat
may
much
less
impact
sar
pseudoviru
cell
entri
investig
role
hspg
sar
pseudoviru
cell
entri
vero
cell
shown
figur
sar
pseudoviru
infect
effici
block
lf
heparin
cell
surfac
hspg
degrad
respect
result
provid
support
evid
involv
hspg
sarscov
cell
entri
vsvg
pseudotyp
viru
usual
use
control
viru
studi
thu
role
hspg
vsvg
pseudotyp
viru
cell
entri
investig
experi
surprisingli
found
solubl
heparin
enzymat
remov
cell
surfac
hspg
effect
inhibit
vsvg
viru
particl
infect
fig
consist
previou
report
use
replicationcompet
vsv
vsvg
pseudotyp
viru
cell
line
includ
human
hela
avian
cer
human
bronchial
tracheal
epitheli
cell
etc
furthermor
previou
report
shown
lf
could
exert
inhibitori
effect
vsv
infect
also
confirm
experi
result
fig
data
suggest
hspg
also
play
import
role
process
vsv
cell
entri
bind
lf
cell
surfac
hspg
may
account
reduct
vsv
infect
date
mani
investig
perform
elucid
rather
complic
process
viral
cell
entri
sum
find
underli
mechan
viral
infect
specul
might
univers
phenomenon
figur
lactoferrin
exert
inhibitori
effect
spike
protein
sar
pseudoviru
bind
cellsurfac
hspg
heparin
neutral
lfmediat
inhibit
bind
cell
treatment
mm
lf
h
cell
incub
heparin
min
concentr
mm
mm
mm
ad
group
detect
bind
cell
describ
error
bar
repres
sd
three
independ
experi
b
inhibit
sar
pseudoviru
infect
cell
lf
partial
neutral
heparin
cell
treat
heparin
min
concentr
mm
mm
mm
mm
lf
ad
group
incub
h
gfpexpress
cell
total
popul
analyz
describ
rel
viral
infect
ratio
measur
compar
percentag
gfp
express
cell
group
bsa
control
error
bar
repres
sd
three
independ
experi
figur
addit
exogen
heparin
enzymat
remov
hs
chain
heparinas
reduc
spike
protein
bind
cell
heparin
block
bind
cell
cell
incub
heparin
min
concentr
mm
mm
mm
ad
group
incub
h
mfi
group
measur
describ
error
bar
repres
sd
three
independ
experi
b
enzymat
degrad
cellsurfac
heparan
sulfat
hs
chain
reduc
bind
treatment
u
heparinas
cell
incub
h
mfi
test
perform
use
method
envelop
virus
tend
util
cellsurfac
hspg
primari
anchor
site
initi
subsequ
cell
entri
recent
studi
reveal
viral
entri
highli
complex
process
usual
involv
variou
molecul
cell
surfac
primari
step
often
initi
lowaffin
bind
attach
site
promot
concentr
virion
cell
surfac
subsequ
bind
highaffin
receptor
trigger
cell
entri
ubiquit
hspg
wide
distribut
mammalian
cell
identifi
initi
dock
site
number
virus
herp
viru
hepat
c
viru
dengu
viru
human
immunodefici
viru
type
foot
mouth
diseas
viru
human
papillomaviru
hepat
b
viru
reveal
hspg
act
primari
bind
site
promot
viral
dock
facilit
subsequ
interact
specif
receptor
furthermor
hspg
function
storag
site
nonpermiss
cell
mediat
tran
infect
present
virus
target
cell
previou
studi
indic
addit
coreceptor
cellular
molecul
requir
sarscov
infect
result
suggest
effici
entri
sarscov
host
cell
requir
involv
hspg
concert
increas
infect
sar
pseudoviru
associ
bind
hs
elimin
cellsurfac
hs
heparinas
addit
exogen
heparin
reduc
abil
viru
bind
cell
surfac
increas
cellular
resist
infect
furthermor
demonstr
murin
coronaviru
util
hspg
receptor
cell
entri
suggest
hspg
may
also
play
import
role
interfer
interact
vero
sar
pseudoviru
lf
heparin
heparinas
lead
reduct
viral
infect
vero
cell
treat
method
mm
lf
mm
heparin
u
heparinas
respect
cell
incub
sar
pseudoviru
describ
method
gfpexpress
cell
total
popul
analyz
flow
cytometri
rel
viral
infect
ratio
measur
compar
percentag
gfp
express
cell
group
control
error
bar
repres
sd
three
independ
experi
b
incub
lf
heparin
degrad
hspg
heparinas
inhibit
sar
pseudoviru
infect
cell
cell
treat
method
describ
process
sarscov
infect
due
similar
spike
protein
structur
two
virus
thu
like
hspg
serv
sarscov
attach
site
facilit
concentr
viru
cell
surfac
well
access
specif
entri
receptor
preliminari
stage
dock
viru
host
cell
mediat
interact
spike
protein
hs
chain
hspg
associ
facilit
bind
sarscov
cellsurfac
receptor
current
wide
accept
model
role
hspg
suggest
transport
extracellular
viru
particl
low
affin
anchor
site
high
affin
specif
entri
receptor
ubiquit
phenomenon
viral
invas
term
viral
surf
weak
revers
interact
viru
dock
site
viru
bind
host
cell
scan
cell
surfac
specif
receptor
sarscov
may
also
adopt
similar
strategi
cell
entri
figur
illustr
hypothet
process
sarscov
infect
howev
sarscov
attach
hspg
alon
enabl
viral
entri
hspg
wide
distribut
surfac
mammalian
cell
howev
target
cell
sarscov
limit
lung
alveolar
epitheli
cell
enterocyt
small
intestin
brush
border
proxim
tubular
cell
kidney
among
other
therefor
hspg
play
import
complex
role
promot
sarscov
infect
entri
process
also
requir
interact
viral
spike
protein
one
coreceptor
molecul
cell
surfac
report
sarscov
util
dcsign
enhanc
infect
studi
confirm
lf
block
interact
dcsign
receptor
dendrit
cell
hiv
glycoprotein
result
inhibit
subsequ
viru
transmiss
find
suggest
lf
may
prevent
sarscov
spread
human
bodi
mechan
reveal
lf
highli
upregul
fold
peripher
blood
mononuclear
cell
sar
patient
lf
usual
present
plasma
extern
secret
exert
wide
varieti
biolog
function
inhibit
infect
microb
includ
bacteria
virus
protozoa
fungi
lf
highli
conserv
protein
approxim
sequenc
homolog
bovin
human
form
therefor
bovin
lf
often
util
substitut
human
lf
similar
function
result
suggest
lf
inhibit
entri
sar
pseudoviru
cell
dosedepend
manner
lf
disrupt
interact
spike
protein
receptor
vitro
howev
lf
inhibit
spike
protein
bind
cell
target
molecul
cell
membran
lf
interact
hspg
previou
threedimension
structur
analys
reveal
lf
carri
highli
cation
charg
molecular
surfac
particularli
ntermin
domain
highli
posit
surfac
charg
characterist
featur
multifunct
protein
mani
studi
demonstr
lf
bind
hspg
cell
membran
high
affin
ntermin
glycosaminoglycanbind
domain
hspg
compos
core
protein
coval
connect
linear
polysulf
heparan
sulfat
polysaccharid
due
abund
carboxyl
sulfat
group
hspg
major
sourc
highli
neg
charg
macromolecul
surround
almost
mammalian
cell
strong
net
neg
charg
permit
hspg
bind
ntermin
glycosaminoglycanbind
domain
lf
electrostat
attract
experi
reveal
lfmediat
inhibit
sarscov
infect
occur
figur
hspg
also
involv
vsvg
viru
cell
entri
cell
treat
mm
lf
mm
heparin
u
heparinas
respect
way
method
use
subsequ
assay
describ
gfpexpress
cell
total
popul
analyz
flow
cytometri
rel
viral
infect
ratio
measur
compar
percentag
gfp
express
cell
group
control
error
bar
repres
sd
three
independ
experi
lf
competit
local
sarscov
anchor
site
provid
hspg
bind
lf
hspg
prevent
preliminari
contact
sarscov
host
cell
thu
prevent
subsequ
cell
entri
summari
lf
may
exert
protect
function
sarscov
invas
two
way
time
one
hand
report
previou
research
lf
enhanc
nk
cell
activ
stimul
neutrophil
aggreg
adhes
immun
defens
hand
lf
curtail
entri
sarscov
host
cell
sarscov
infect
lf
may
potenti
therapeut
applic
drug
candid
treatment
sar
diseas
sinc
sar
outbreak
novemb
still
effect
prevent
vaccin
antivir
therapeut
strategi
avail
combat
deadli
viru
although
great
progress
made
understand
molecular
mechan
sarscov
life
cycl
investig
perform
elucid
subtl
process
sarscov
cell
entri
provid
deeper
insight
ration
drug
design
treatment
sar
diseas
